Delineating the Molecular and Phenotypic Spectrum of the
CNGA3
achromatopsia
consanguineous families
exome sequencing
missense variants
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
29 03 2022
29 03 2022
Historique:
received:
31
01
2022
revised:
10
03
2022
accepted:
21
03
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
27
4
2022
Statut:
epublish
Résumé
Cone photoreceptor dysfunction represents a clinically heterogenous group of disorders characterized by nystagmus, photophobia, reduced central or color vision, and macular dystrophy. Here, we described the molecular findings and clinical manifestations of achromatopsia, a partial or total absence of color vision, co-segregating with three known missense variants of CNGA3 in three large consanguineous Pakistani families. Fundus examination and optical coherence tomography (OCT) imaging revealed myopia, thin retina, retinal pigment epithelial cells loss at fovea/perifovea, and macular atrophy. Combination of Sanger and whole exome sequencing revealed three known homozygous missense variants (c.827A>G, p.(Asn276Ser); c.847C>T, p.(Arg283Trp); c.1279C>T, p.(Arg427Cys)) in CNGA3, the α-subunit of the cyclic nucleotide-gated cation channel in cone photoreceptor cells. All three variants are predicted to replace evolutionary conserved amino acids, and to be pathogenic by specific in silico programs, consistent with the observed altered membrane targeting of CNGA3 in heterologous cells. Insights from our study will facilitate counseling regarding the molecular and phenotypic landscape of CNGA3-related cone dystrophies.
Identifiants
pubmed: 35456423
pii: genes13040617
doi: 10.3390/genes13040617
pmc: PMC9031457
pii:
doi:
Substances chimiques
CNGA3 protein, human
0
Cyclic Nucleotide-Gated Cation Channels
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR077563
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC016295
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01DC016295
Pays : United States
Références
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
JAMA Ophthalmol. 2014 Sep;132(9):1076-83
pubmed: 24903488
Invest Ophthalmol Vis Sci. 2012 Mar 01;53(3):1117-29
pubmed: 22247469
Prog Histochem Cytochem. 2009;44(3):125-72
pubmed: 19822255
Hum Genet. 2007 May;121(3-4):433-9
pubmed: 17265047
Nat Genet. 1998 Jul;19(3):257-9
pubmed: 9662398
Int J Mol Sci. 2018 Mar 07;19(3):
pubmed: 29518895
Am J Hum Genet. 2001 Oct;69(4):722-37
pubmed: 11536077
Front Physiol. 2015 Jun 09;6:177
pubmed: 26106334
Ophthalmic Genet. 2018 Jan-Feb;39(1):108-114
pubmed: 28929832
Nat Commun. 2011 Aug 30;2:457
pubmed: 21878911
Mol Psychiatry. 2017 Nov;22(11):1604-1614
pubmed: 27457812
Elife. 2017 Jun 26;6:
pubmed: 28650316
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3864-71
pubmed: 17652762
Mol Pharmacol. 2021 Jun;99(6):460-468
pubmed: 33827965
Physiol Rev. 2002 Jul;82(3):769-824
pubmed: 12087135
Prog Mol Biol Transl Sci. 2019;161:1-27
pubmed: 30711023
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):821-832
pubmed: 28159970
Eur J Neurosci. 2008 May;27(9):2391-401
pubmed: 18445228
Eur J Hum Genet. 2015 Apr;23(4):473-80
pubmed: 25052312
PLoS One. 2017 Nov 13;12(11):e0188032
pubmed: 29131863
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Am J Ophthalmol. 2013 Dec;156(6):1211-1219.e2
pubmed: 23972307
Br J Ophthalmol. 2015 Apr;99(4):571-6
pubmed: 25637600
Jpn J Ophthalmol. 2011 Nov;55(6):676-80
pubmed: 21912902
Br J Ophthalmol. 2021 May 18;:
pubmed: 34006508
Am J Hum Genet. 2017 Jan 5;100(1):75-90
pubmed: 28041643
Biochem Biophys Res Commun. 2004 Oct 1;322(4):1123-30
pubmed: 15336959
Handb Exp Pharmacol. 2009;(191):111-36
pubmed: 19089328
J Biol Chem. 2016 Apr 15;291(16):8721-34
pubmed: 26893377